Brief: Briacell Therapeutics Says Will Voluntarily Delist Its Common Shares From Trading On Frankfurt Stock Exchange Effective August 19
17/08/2021 20:36
Aug 17 (Reuters) - Briacell Therapeutics Corp BCT.V :
* BRIACELL THERAPEUTICS CORP - WILL VOLUNTARILY DELIST ITS COMMON SHARES FROM TRADING ON
FRANKFURT
STOCK EXCHANGE, OR FWB, EFFECTIVE AUGUST 19
* BRIACELL THERAPEUTICS - COMMON SHARES WILL CONTINUE TO BE LISTED ON NASDAQ CAPITAL MARKET
UNDER
SYMBOL “BCTX” AND ON TSXV UNDER SYMBOL “BCT”
* BRIACELL THERAPEUTICS - CO’S TRADEABLE WARRANTS WILL ALSO CONTINUE TO BE LISTED ON NASDAQ
CAPITAL MARKET UNDER SYMBOL “BCTXW”
* BRIACELL THERAPEUTICS CORP - THE DELISTING FROM THE FWB IS MEANT TO REDUCE COST AND
COMPLEXITY
Source text - https://bit.ly/3g6wGG3
Further company coverage: BCT.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Briacell Therapeutics
See all newsBrief: Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share
Brief: Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer
Brief: Briacell Expands Pipeline To Include An Ovarian Cancer Immunotherapy Candidate, Bria-Ova+™
Brief: Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients
Brief: Briacell Adds Nyu Langone Health’S Perlmutter Cancer Center As Clinical Site In Pivotal Phase 3 Breast Cancer Study